| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | 详情 |
| I811712 | MACKLIN | 异烟肼 | 99% | 44元/25g; 100元/100g; 365元/500g; 1499元/2.5kg; | 展开 |
储存：2~8°C,干燥,密封 状态：白色到灰白色粉末 |
| I811711 | MACKLIN | 异烟肼 | 98% | 34元/25g; 86元/100g; 323元/500g; 1485元/2.5kg; | 展开 |
储存：2~8°C,干燥,密封 状态：白色到灰白色粉末 |
| I794569 | MACKLIN | 异烟肼 | 10mM in DMSO | 450元/1ml; | 展开 |
|
| I0138 | TCI | Isonicotinic Acid Hydrazide | >98.0%(T)(HPLC) | 145元/25G; 245元/100G; 990元/500G; | 展开 |
基本信息 | 纯度/分析方法 | >98.0%(T)(HPLC) | | 分子式/分子量 | C6H7N3O = 137.14 | | 外观与形状(20℃) | 固体 | | 储存在惰性气体下 | 存放于惰性气体之中 | | 应避免的情况 | 空气 | | Reaxys-RN | 119374 | | PubChem物质ID | 87571526 | | SDBS (AIST Spectral DB) | 1853 | | Merck Index (14) | 5186 | | MDL编号 | MFCD00006426 |
技术规格 | Appearance | White to Almost white powder to crystal | | Purity(HPLC) | min. 98.0 area% | | Purity(Nonaqueous Titration) | min. 98.0 % | | Solubility in Water | almost transparency | | Melting point | 170.0 to 173.0 ℃ |
物性(参考值) 安全信息 | 图形或危害标志 |   | | 信号词 | 警告 | | 危险性说明 | H302 : 吞咽有害。
H315 : 造成皮肤刺激。
H319 : 造成严重眼刺激。
H371 : 可能损害器官。
H373 : 长期或反复接触可能损害器官。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。
P260 : 不要吸入粉尘/ 烟/ 气体/ 烟雾/ 蒸气/ 喷雾。
P270 : 使用本产品时不要进食、饮水或吸烟。
P264 : 作业后彻底清洗皮肤。
P280 : 戴防护手套/戴防护眼罩/戴防护面具。
P302 + P352 : 如皮肤沾染：用水充分清洗。
P337 + P313 : 如仍觉眼刺激：求医/就诊。
P305 + P351 + P338 : 如进入眼睛：用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出，取出隐形眼镜。继续冲洗。
P308+P311 : 如接触到或有疑虑：呼叫急救中心/医生。
P362+P364 : 脱掉沾污的衣服，清洗后方可重新使用。
P332 + P313 : 如发生皮肤刺激：求医/就诊。
P301 + P312 + P330 : 如误吞咽：如感觉不适，呼叫急救中心/医生。漱口。
P405 : 存放处须加锁。
|
相关法规 |
| 225949 | J&K | Isonicotinic Acid Hydrazide | 99% | 87元/25G; 195元/100G; 776元/500G; | 展开 |
基本信息 | 分子式 | C6H7N3O | | 分子量 | 137.14 | | 熔点 | 171-173 | | MDL编码 | MFCD00006426 | | Beilstein | 119374 | | Merck | 14,5186 | | EINECS 编号 | 200-214-6 |
安全信息 | 图形或危害标志 | | | 提示语 | Warning | | 危险说明 | H302
H315
H316 | | 防范说明 | P280
P305+P351+P338 | | WGK | 3 | | RTECS | NS1751850 | | TSCA | 是 |
|
| A10583 | Alfa Aesar | Isonicotinic Acid Hydrazide | 98+% | 197元/50g; 374元/100g; 1289元/500g; 2430元/1000g; | 展开 |
应用
Used for fluorescent HPLC detection of delta 4-3-ketosteroids 基本信息 MDL
MFCD00006426 EINECS
200-214-6 分子式
C6H7N3O 分子量
137.14 熔点
169-174° 灵敏度
Air Sensitive. Store under Argon. Ambient temperatures. 形态
Powder Beilstein
119374 Merck
14,5186 GHS危害和防范说明 GHS符号
Hazard Statements
H302-H315-H319-H335
Harmful if swallowed.Causes skin irritation.Causes serious eye irritation.May cause respiratory irritation. Precautionary Statements
P261-P280a-P305+P351+P338-P304+P340-P405-P501a
Avoid breathing dust/fume/gas/mist/vapours/spray.Wear protective gloves and eye/face protection.IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing.Store locked up.Dispose of contents/container in accordance with local/regional/national/international regulations. 安全信息 危险类别
22-36/37/38
Harmful if swallowed.Irritating to eyes, respiratory system and skin. 安全等级
26-36/37-60
In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.Wear suitable protective clothing and gloves.This material and its container must be disposed of as hazardous waste 欧盟危险品标志
 RTECS
NS1751850 TSCA
是 |
| C12260 | Alfa Aesar | Isonicotinic Acid Hydrazide | 99% | 537元/5g; 806元/100g; 3230元/500g; | 展开 |
基本信息 Ref#
12260 MDL
6426 分子式
C6 H7 N3 O 分子量
137.14 形态
White powder |
| 1349706 | USP | Isoniazid | United States Pharmacopeia (USP) Reference Standard | 3231.47元/200 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.
For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 分析说明 These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind. 其他说明 USP issued SDS can be found here.
Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | MDL编号 | MFCD00006426 | | PubChem化学物质编号 | 329750199 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | mp | 171-173 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
| I0500000 | | Isoniazid | European Pharmacopoeia (EP) Reference Standard | 1277.32元/ ; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | MDL编号 | MFCD00006426 | | PubChem化学物质编号 | 329815311 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | agency | EP Reference Standard | | manufacturer/tradename | EDQM | | mp | 171-173 ℃ (lit.) | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
| I3377 | Supelco | Isoniazid | analytical standard, ≥99% (TLC) | 262.14元/5 G; 1138.64元/50 G; 2259.77元/250 G; | 展开 |
产品说明 一般描述 化学结构式：吡啶
异烟肼是一类具有抗分枝杆菌活性的药物。用于结核病的治疗。 应用 参考产品的检验报告，了解更多关于合适仪器技术的信息。联系技术服务部寻求进一步支持。 包装 5, 50, 250 g in poly bottle 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | EC 号 | 200-214-6 | | MDL编号 | MFCD00006426 | | PubChem化学物质编号 | 329815370 | | NACRES | NA.24 |
产品性质 | 质量水平 | 100 | | 等级 | analytical standard | | 测定 | ≥99% (TLC) | | technique(s) | HPLC: suitable
gas chromatography (GC): suitable | | mp | 171-173 ℃ (lit.) | | 荧光 | λex 360 nm; λem 450 nm (thiol adduct) | | 抗生素抗菌谱 | mycobacteria | | application(s) | forensics and toxicology
pharmaceutical (small molecule) | | 格式 | neat | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 | | 个人防护装备 | dust mask type N95 (US), Eyeshields, Gloves |
|
| V900688 | Supelco | Isoniazid | Vetec™, reagent grade, 98% | 251.3元/100 G; 1055.78元/500 G; | 展开 |
产品说明 包装 100, 500 g in poly bottle 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 法律信息 Vetec is a trademark of sigma-aldrich International GmbH 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | EC 号 | 200-214-6 | | MDL编号 | MFCD00006426 | | PubChem化学物质编号 | 329830060 |
产品性质 | 等级 | reagent grade | | 产品线 | Vetec™ | | 测定 | 98% | | mp | 171-173 ℃ (lit.) | | 格式 | neat | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
| PHR1932 | Supelco | Isoniazid | Pharmaceutical Secondary Standard; Certified Reference Material | 2391.32元/500 MG; | 展开 |
产品说明 一般描述 药物二级标准品CRM，为制药行业QC实验室及生产质量控制和研发，提供了一种方便、高性价比且符合相关法规的替代方案。 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 分析说明 这些二级标准品可溯源到USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 欲查看此物质的分析证书样本，请在下面的对话框中输入 LRAC3171。这只是一个示例证书，可能与您收到的批次不符。 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | EC 号 | 200-214-6 | | MDL编号 | MFCD00006426 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material
pharmaceutical secondary standard | | 形式 | powder | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | mp | 171-173 ℃ (lit.) | | application(s) | pharmaceutical | | 药典可追溯性 | traceable to BP 1083
traceable to PhEur I0500000
traceable to USP 1349706 | | 储存温度 | 2-8℃ | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
安全信息 | 象形图 | | | 警示用语： | Warning | | 危险声明 | H302 - H315 | | 预防措施声明 | P264 - P270 - P280 - P301 + P312 - P302 + P352 - P332 + P313 | | 危险分类 | Acute Tox. 4 Oral - Skin Irrit. 2 | | 储存分类代码 | 11 - Combustible Solids | | WGK | WGK 3 |
|
| BP1083 | | Isoniazid | British Pharmacopoeia (BP) Reference Standard | 2290.11元/100 MG; | 展开 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 生化/生理作用 针对结核菌的抗生素，抑制分枝菌酸的生物合成。由肝脏 N-乙酰转移酶 (NAT) 和 细胞色素 P450 2E1 (CYP2E1) 代谢形成肝毒素。选择性诱导 CYP2E1 的表达。可逆抑制 CYP2C19 和 CYP3A4 的活性，在临床相关浓度下机械性地灭活 CYP1A2、CYP2A6、CYP2C19 和 CYP3A4。 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C6H7N3O | | 分子量 | 137.14 | | Beilstein | 119374 | | MDL编号 | MFCD00006426 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | mp | 171-173 ℃ (lit.) | | 格式 | neat | | 储存温度 | 2-8℃ | | SMILES string | NNC(=O)c1ccncc1 | | InChI | 1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10) | | InChI key | QRXWMOHMRWLFEY-UHFFFAOYSA-N |
|
| 236758 | Fluorochem | Isonicotinohydrazide | 95% | 660元/100g; 7876元/1kg; 19690元/5kg; | 展开 |
基本信息 | CAS Number | 54-85-3 | | MDL Number | MFCD00006426 |
安全信息 | 图形或危害标志 | | | 危险性说明 | H302: Harmful if swallowed.
H315: Causes skin irritation.
H319: Causes serious eye irritation.
H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed.
P260: Do not breathe .
P261: Avoid breathing
P264: Wash hands thoroughly after handling.
P270: Do not eat, drink or smoke when using this product.
P271: Use only outdoors or in a well-ventilated area.
P280: Wear .
P301 + P312: IF SWALLOWED: Call a POISON CENTER or doctor/physician if you feel unwell.
P302 + P352: IF ON SKIN: Wash with plenty of soap and water.
P304: IF INHALED: .
P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P312: Call a POISON CENTER or doctor/physician if you feel unwell.
P321: Specific treatment (see . on this label).
P330: Rinse mouth.
P332 + P313: If skin irritation occurs: Get medical advice/ attention.
P337 + P313: If eye irritation persists: Get medical advice/attention.
P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing.
P362: Take off contaminated clothing and wash before reuse.
P403: Store in a well-ventilated place.
P403 + P233: Store in a well-ventilated place. Keep container tightly closed.
P405: Store locked up.
P501: Dispose of contents/container to local regulations.
|
|
m.cnreagent.com